BioNTech SE (BNTX) Cash from Operations (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash from Operations data on file, last reported at 360271467.8 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations rose 172.77% year-over-year to 360271467.8; the trailing twelve-month figure through Dec 2025 stood at 617578689.96 (up 192.86% YoY), and the FY2025 full-year result was 515193902.59, up 132.12% from the prior year.
• Cash from Operations slipped to 360271467.8 in Q4 2025, from 912681309.82 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4818442194.59 in Q3 2022 to a low of 821206181.94 in Q1 2025.
• A 5-year average of 1159382522.17 and a median of 603130291.55 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 1210566204.64% in 2022 and plunged 179.46% in 2024, its largest moves.
• Tracing BNTX's Cash from Operations over 5 years: stood at 228222204.75 in 2021, then surged by 270.69% to 845989115.3 in 2022, then increased by 8.22% to 915517268.55 in 2023, then tumbled by 154.08% to 495080248.9 in 2024, then jumped by 172.77% to 360271467.8 in 2025.
• Business Quant data shows BNTX's Cash from Operations at 360271467.8 in Q4 2025, 912681309.82 in Q3 2025, and 165832094.29 in Q2 2025.